Management of knee osteoarthritis: an evidence-based review of treatment options.

Division of Rheumatology, Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Le Journal médical libanais. The Lebanese medical journal 60(4):237-42.
Source: PubMed

ABSTRACT Osteoarthritis is the most common form of arthritis, and its incidence increases rapidly with age. Osteoarthritis is a progressive degenerative disease, and treatment must evolve with disease progression. Several classes of medications and treatment modalities have been used to relieve pain and preserve function. Most have been studied extensively but results of even well-designed trials can diverge. Furthermore, effect of a drug (beneficial or adverse) in an individual patient is not always predictable and may differ from the class effect. A short treatment trial may be necessary to determine efficacy. This potential discrepancy between statistical outcome and individual result is captured in the guidelines, to whatever extent possible. A summary of recommendations for select interventions compiled from multiple guidelines is presented in table II. In closing, interpretation of guideline recommendations, and how they were derived, must be clarified, since they have been a source of confusion and misinterpretation. Level of evidence (LoE) refers to the source from which the evidence was derived. It describes the quality of evidence and academic vigor, with meta-analysis of RCT being of strongest quality and expert opinion the lowest. The strength of effect describes how much of a clinical effect (usually benefit) is expected from the intervention. The strength of recommendation incorporates LoE and strength of effect, as well as cost, safety, and feasibility. An intervention with a high LoE does not necessarily trigger a strong recommendation. For example, NSAIDs have a greater effect on pain reduction than acetaminophen in most studies, but carries a lower recommendation due to concerns with long-term safety. Total knee arthroplasty has a LoE of III since no blinded RCT have studied the procedure, yet it carries a strong recommendation in advanced OA. In the five years between the publication of the EULAR and the OARIS guidelines (2003-2008), new studies were published explaining, in part, the difference in recommendations among the agencies. Future guidelines will undoubtedly evolve further.


Available from: Mira Merashli, Jan 26, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mangiferin is a natural immunomodulator found in plants including mango trees. The effects of mangiferin on chondrogenesis and cartilage repair have not yet been reported. This study was designed to determine the effect of mangiferin on chondrogenic differentiation in IL-1β-stimulated mesenchymal stem cells (MSCs) from subchondral bone and to explore the mechanisms underlying these effects. MSCs were isolated from the subchondral bone of rabbit and treated with mangiferin alone and/or interleukin-1β (IL-1β). Mangiferin induced chondrogenic differentiation in MSCs by upregulating transforming growth factor (TGF)-β, bone morphogenetic protein (BMP)-2, and BMP-4 and several key markers of chondrogenesis, including sex-determining region Y-box (SRY-box) containing gene 9 (SOX9), type 2α1 collagen (Col2α1), cartilage link protein, and aggrecan. In IL-1β-stimulated MSCs, mangiferin significantly reversed the production of TGF-β, BMP-2, BMP-4, SOX9, Col2α1, cartilage link protein, and aggrecan, as well as matrix metalloproteinase (MMP)-1, MMP-13, and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS5). Mangiferin upregulated the phosphorylation of Smad 2, Smad 3, Smad 1/5/8, and SOX9 in IL-1β-stimulated MSCs. In the presence of mangiferin, SOX9 siRNA suppressed the activation of Smad 2, Smad 3, Smad 1/5/8, aggrecan, and Col2α1 expression. In conclusion, mangiferin exhibits both chondrogenic and chondroprotective effects on damaged MSCs and mediates these effects by targeting multiple aspects of the Smad and SOX9 signaling pathways.
    International Journal of Molecular Sciences 09/2014; 15(9):16025-16042. DOI:10.3390/ijms150916025 · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: This work aimed to investigate the biochemical changes associated with low-level laser therapy (LLLT) using 660 and 780 nm, on a well-established experimental model of osteoarthritis (OA) in the knees of rats with induced collagenase, using histomorphometry and Raman spectroscopy. Material and methods: Thirty-six Wistar rats were divided into four groups: control (GCON, n=9), collagenase without treatment (GCOL, n=9), collagenase with LLLT 660 nm treatment (G660, n=8), and collagenase with LLLT 780 nm treatment (G780, n=10). LLLT protocol was: 30 mW power output, 10 sec irradiation time, 0.04 cm(2) spot size, 0.3 J energy, 0.75 W/cm(2) irradiance, and 7.5 J/cm(2) fluence per session per day, during 14 days. Then, knees were withdrawn and submitted to histomorphometry and Raman spectroscopy analysis. Principal components analysis (PCA) and Mahalanobis distance were employed to characterize the spectral findings. Results: Histomorphometry revealed a significant increase in the amount of collagen III for the group irradiated with 660 nm. The Raman bands at 1247, 1273, and 1453 cm(-1) (from principal component score PC2), attributed to collagen type II, and 1460 cm(-1) (from PC3), attributed to collagen type III, suggested that the LLLT causes acceleration in cellular activity, especially on the cells that repair cartilage, accelerating the breakdown of cartilage destroyed by collagenase and stimulating the fibroblast to synthesize repairing collagen III. Conclusions: LLLT accelerated the initial breakdown of cartilage destroyed by collagenase and stimulated the fibroblast to synthesize the repairing collagen III, suggesting a beneficial effect of LLLT on OA.
    Photomedicine and Laser Surgery 02/2015; 33(3). DOI:10.1089/pho.2014.3744 · 1.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this review article, we describe benefits and disadvantages of the established histochemical methods for studying articular cartilage tissue under normal, pathological and experimental conditions. We illustrate the current knowledge on cartilage tissue based on histological and immunohistochemical aspects, and in conclusion we provide a short overview on the degeneration of cartilage, such as osteoarthritis. Adult articular cartilage has low capacity to repair itself, and thus even minor injuries may lead to progressive damage and osteoarthritic joint degeneration, resulting in significant pain and disability. Numerous efforts have been made to implement the knowledge in the study of cartilage in the last years, and histochemistry proved to be an especially powerful tool to this aim.
    European journal of histochemistry: EJH 04/2014; 58(2):2371. DOI:10.4081/ejh.2014.2371 · 2.24 Impact Factor